Video: The effects of the pandemic on people living with dementia

Dr. Katya Numbers from the Centre for Healthy Brain Ageing (CHeBA) discusses how the COVID-19 pandemic has posed unique risks to people with Alzheimer’s disease and dementia. Dr. Numbers’ research has revealed people living with dementia have a relatively high risk of contracting severe COVID-19 and are also at risk of neuropsychiatric disturbances as a result of lockdown measures and […]

Read more

No, vaccine side effects don’t tell you how well your immune system will protect you from COVID-19

If someone gets a headache or feels a bit under the weather after receiving a COVID-19 vaccine, it’s become common to hear them say something like “Oh, it just means my immune system is really working hard.” On the flip side, when people don’t notice any side effects, they sometimes worry the shot isn’t doing its job or their immune […]

Read more

Study reveals cancer immunotherapy patients at most risk of life-threatening side effects

Many patients with cancer receive immune checkpoint inhibitors that strengthen their immune response against tumor cells. While the medications can be life-saving, they can also cause potentially life-threatening side effects in internal organs. This double-edged sword makes it challenging for clinicians to decide who should be considered candidates for treatment. A new analysis led by researchers at Massachusetts General Hospital […]

Read more

Faulty metabolism of Parkinson’s medication in the brain linked to severe side effects

Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson’s disease, declines in efficacy after a few years’ use has been unknown. A side effect that then often occur is involuntary movements. A Swedish–French collaboration, led from Uppsala University, has now been able to connect the problems with defective metabolism of L-Dopa in the […]

Read more

New analysis method for predicting the risks and effects of immunotherapy

In a new study, researchers at Uppsala University have been able to show differences in how rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphatic leukemia. This has awakened hopes that this analysis method could pave the way for important breakthroughs in immunotherapy research and treatment. Immunotherapy—using the body’s own immune […]

Read more

Predicting the risk of severe side effects of cancer treatment

The risk of serious adverse effects on the blood status and bone marrow of patients during chemotherapy can be predicted by a model developed at Linköping University, Sweden. This research may make it possible to use genetic analysis to identify patients with a high probability of side effects. The study has been published in npj Systems Biology and Applications. It […]

Read more

Blocking energy pathway reduces GVHD while retaining anti-cancer effects of T-cells

MUSC Hollings Cancer Center researchers identified that blocking an alternative energy pathway for T-cells after hematopoietic stem cell transplant helps reduce graft-versus-host disease (GVHD) in an animal model of leukemia. Xue-Zhong Yu, M.D., who also is associate director of Basic Science at Hollings, and collaborators at the Indiana University School of Medicine discovered that donor T-cells must have the key […]

Read more

New study shows the effects of obesity mirror those of aging

Globally, an estimated 1.9 billion adults and 380 million children are overweight or obese. According to the World Health Organization, more people are dying from being overweight than underweight. Researchers at Concordia are urging health authorities to rethink their approach to obesity. In their paper published in the journal Obesity Reviews, the researchers argue that obesity should be considered premature […]

Read more

Chemicals between us: Surprising effects of oxytocin on cocaine addiction

A team of addiction researchers at the Medical University of South Carolina (MUSC) report in Psychopharmacology that oxytocin, a hormone produced naturally in the hypothalamus, has significant gender differences when used as a treatment for cocaine-addicted individuals with a history of childhood trauma. The MUSC team was led by Jane E. Joseph, Ph.D., a professor in the Department of Neuroscience, […]

Read more
1 2 3